Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2888 | 2830 | 33.2 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
2888 | 2 | HEART KIDNEY//FENOLDOPAM//IBOPAMINE | 2830 |
4637 | 1 | HEART KIDNEY//FENOLDOPAM//DA1 RECEPTOR | 1751 |
13982 | 1 | INTRATHECAL DOMPERIDONE//SPINAL DOPAMINE D 2 RECEPTORS//HYPOTENSION AND BRADYCARDIA | 800 |
25512 | 1 | IBOPAMINE//EPININE//DOPAMINE PRODRUG | 279 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEART KIDNEY | address | 330968 | 2% | 68% | 45 |
2 | FENOLDOPAM | authKW | 238254 | 2% | 41% | 54 |
3 | IBOPAMINE | authKW | 229172 | 1% | 59% | 36 |
4 | RECEPTORS DOPAMINE | authKW | 145022 | 1% | 61% | 22 |
5 | GLUDOPA | authKW | 140962 | 0% | 93% | 14 |
6 | DA1 RECEPTOR | authKW | 139803 | 1% | 72% | 18 |
7 | RENAL DOPAMINE | authKW | 117464 | 0% | 78% | 14 |
8 | CARDIOVASC STUDIES | address | 99849 | 1% | 51% | 18 |
9 | GRK4 | authKW | 91374 | 0% | 71% | 12 |
10 | DOPAMINE RECEPTORS | authKW | 78148 | 4% | 6% | 126 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 11762 | 38% | 0% | 1085 |
2 | Physiology | 5945 | 16% | 0% | 465 |
3 | Peripheral Vascular Diseases | 5579 | 14% | 0% | 384 |
4 | Urology & Nephrology | 2132 | 9% | 0% | 245 |
5 | Cardiac & Cardiovascular System | 1606 | 10% | 0% | 297 |
6 | Endocrinology & Metabolism | 994 | 8% | 0% | 237 |
7 | Medicine, Research & Experimental | 431 | 6% | 0% | 163 |
8 | Neurosciences | 161 | 7% | 0% | 201 |
9 | Chemistry, Medicinal | 111 | 3% | 0% | 75 |
10 | Cell Biology | 29 | 4% | 0% | 110 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEART KIDNEY | 330968 | 2% | 68% | 45 |
2 | CARDIOVASC STUDIES | 99849 | 1% | 51% | 18 |
3 | UNIT DEV NEPHROL | 26965 | 0% | 50% | 5 |
4 | ATHEROSCLEROSIS UNITMEMBRANE SIGNALING NETWO | 24272 | 0% | 75% | 3 |
5 | PEDIAT PHYSIOL BIOPHYS | 22838 | 0% | 35% | 6 |
6 | CATECOLAMINAS | 21576 | 0% | 100% | 2 |
7 | MED MOL NEUROCHEM PEDIAT | 21576 | 0% | 100% | 2 |
8 | PHYS HEALTHCARE | 21576 | 0% | 100% | 2 |
9 | MED AUTOMAT | 15858 | 0% | 29% | 5 |
10 | D ING HOSP | 15012 | 2% | 3% | 50 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 30780 | 2% | 6% | 49 |
2 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 19439 | 2% | 3% | 60 |
3 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 18077 | 2% | 4% | 48 |
4 | HYPERTENSION | 13618 | 4% | 1% | 121 |
5 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 12625 | 3% | 1% | 88 |
6 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 7474 | 3% | 1% | 88 |
7 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 5147 | 1% | 1% | 33 |
8 | AMERICAN JOURNAL OF HYPERTENSION | 4493 | 2% | 1% | 50 |
9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 4018 | 3% | 0% | 90 |
10 | JOURNAL DE PHARMACOLOGIE | 3875 | 0% | 3% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FENOLDOPAM | 238254 | 2% | 41% | 54 | Search FENOLDOPAM | Search FENOLDOPAM |
2 | IBOPAMINE | 229172 | 1% | 59% | 36 | Search IBOPAMINE | Search IBOPAMINE |
3 | RECEPTORS DOPAMINE | 145022 | 1% | 61% | 22 | Search RECEPTORS+DOPAMINE | Search RECEPTORS+DOPAMINE |
4 | GLUDOPA | 140962 | 0% | 93% | 14 | Search GLUDOPA | Search GLUDOPA |
5 | DA1 RECEPTOR | 139803 | 1% | 72% | 18 | Search DA1+RECEPTOR | Search DA1+RECEPTOR |
6 | RENAL DOPAMINE | 117464 | 0% | 78% | 14 | Search RENAL+DOPAMINE | Search RENAL+DOPAMINE |
7 | GRK4 | 91374 | 0% | 71% | 12 | Search GRK4 | Search GRK4 |
8 | DOPAMINE RECEPTORS | 78148 | 4% | 6% | 126 | Search DOPAMINE+RECEPTORS | Search DOPAMINE+RECEPTORS |
9 | G PROTEIN COUPLED RECEPTOR KINASE 4 | 75516 | 0% | 100% | 7 | Search G+PROTEIN+COUPLED+RECEPTOR+KINASE+4 | Search G+PROTEIN+COUPLED+RECEPTOR+KINASE+4 |
10 | GAMMA L GLUTAMYL 5 HYDROXY L TRYPTOPHAN | 64728 | 0% | 100% | 6 | Search GAMMA+L+GLUTAMYL+5+HYDROXY+L+TRYPTOPHAN | Search GAMMA+L+GLUTAMYL+5+HYDROXY+L+TRYPTOPHAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ARMANDO, I , VILLAR, VAM , JOSE, PA , (2011) DOPAMINE AND RENAL FUNCTION AND BLOOD PRESSURE REGULATION.COMPREHENSIVE PHYSIOLOGY. VOL. 1. ISSUE 3. P. 1075 -1117 | 357 | 55% | 13 |
2 | JOSE, PA , EISNER, GM , FELDER, RA , (1998) RENAL DOPAMINE RECEPTORS IN HEALTH AND HYPERTENSION.PHARMACOLOGY & THERAPEUTICS. VOL. 80. ISSUE 2. P. 149 -182 | 285 | 69% | 134 |
3 | WANG, XY , VILLAR, VAM , ARMANDO, I , EISNER, GM , FELDER, RA , JOSE, PA , (2008) DOPAMINE, KIDNEY, AND HYPERTENSION: STUDIES IN DOPAMINE RECEPTOR KNOCKOUT MICE.PEDIATRIC NEPHROLOGY. VOL. 23. ISSUE 12. P. 2131 -2146 | 139 | 69% | 14 |
4 | APERIA, AC , (2000) INTRARENAL DOPAMINE: A KEY SIGNAL IN THE INTERACTIVE REGULATION OF SODIUM METABOLISM.ANNUAL REVIEW OF PHYSIOLOGY. VOL. 62. ISSUE . P. 621-647 | 106 | 82% | 174 |
5 | ZENG, CY , ARMANDO, I , LUO, YJ , EISNER, GM , FELDER, RA , JOSE, PA , (2008) DYSREGULATION OF DOPAMINE-DEPENDENT MECHANISMS AS A DETERMINANT OF HYPERTENSION: STUDIES IN DOPAMINE RECEPTOR KNOCKOUT MICE.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. VOL. 294. ISSUE 2. P. H551-H569 | 143 | 56% | 25 |
6 | HUSSAIN, T , LOKHANDWALA, MF , (2003) RENAL DOPAMINE RECEPTORS AND HYPERTENSION.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 228. ISSUE 2. P. 134-142 | 89 | 92% | 114 |
7 | ASGHAR, M , TAYEBATI, SK , LOKHANDWALA, MF , HUSSAIN, T , (2011) POTENTIAL DOPAMINE-1 RECEPTOR STIMULATION IN HYPERTENSION MANAGEMENT.CURRENT HYPERTENSION REPORTS. VOL. 13. ISSUE 4. P. 294 -302 | 88 | 81% | 12 |
8 | ZENG, CY , ZHANG, M , ASICO, LD , EISNER, GM , JOSE, PA , (2007) THE DOPAMINERGIC SYSTEM IN HYPERTENSION.CLINICAL SCIENCE. VOL. 112. ISSUE 11-12. P. 583-597 | 111 | 67% | 50 |
9 | ZENG, CY , SANADA, H , WATANABE, H , EISNER, GM , FELDER, RA , JOSE, PA , (2004) FUNCTIONAL GENOMICS OF THE DOPAMINERGIC SYSTEM IN HYPERTENSION.PHYSIOLOGICAL GENOMICS. VOL. 19. ISSUE 3. P. 233-246 | 132 | 60% | 62 |
10 | O'CONNELL, DP , AHERNE, AM , (2000) RENAL DOPAMINERGIC MECHANISMS AND HYPERTENSION: A CHRONOLOGY OF ADVANCES.CLINICAL AND EXPERIMENTAL HYPERTENSION. VOL. 22. ISSUE 3. P. 217 -249 | 112 | 69% | 2 |
Classes with closest relation at Level 2 |